Underwriting of Options
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Later from Arovella Therapeutics
- SUDA receives $0.7m R&D tax incentive refund
- Half Yearly Report and Accounts (including Appendix 4D)
- Westcoast Expands To East Coast
- Appendix 4D Half Year Ended 31 December 2013
- Suda Completes Successful $5.6m Capital Raising
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics